eGenesis Provides Clinical Update on EGEN-2784 Expanded Access Study in Kidney Failure Patients

eGenesis Reports Sustained Kidney Function and Successful Human Transplantation Following Genetically Engineered Pig Kidney Transplants eGenesis, a biotechnology company focused on developing genetically engineered organs designed for transplantation into humans,…

Read MoreeGenesis Provides Clinical Update on EGEN-2784 Expanded Access Study in Kidney Failure Patients

SinglePass Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study

SinglePass Biopsy Closure Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study SinglePass, Inc., developer of the SinglePass biopsy closure device, has announced the publication of…

Read MoreSinglePass Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study

Invivoscribe Launches Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Sample Preparation

Invivoscribe Begins Commercial Shipments of PrepQuant™ System to Advance High-Sensitivity MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, has announced the start of…

Read MoreInvivoscribe Launches Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Sample Preparation

Rapalogix Health Establishes Research Lab at Princeton Innovation Center BioLabs to Advance Next-Generation Rapalogs

Rapalogix Health Expands Research Capabilities with New Laboratory at Princeton Innovation Center BioLabs Rapalogix Health, a biotechnology company focused on developing longevity-based approaches to skin health, has announced the establishment…

Read MoreRapalogix Health Establishes Research Lab at Princeton Innovation Center BioLabs to Advance Next-Generation Rapalogs